Terremoto Biosciences, Inc.

Biotech South San Francisco, CA

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
South San Francisco, CA
Street
230 East Grand Avenue, Suite 200
Zip
94080

Offering

Total offering
$108.6M
Amount sold
$40.7M
First sale
Apr 10, 2026
Min investment
$0
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
14

How this filing compares

Ranked #2 of 47 Biotech filings in April 2026 by offering amount.

Median Biotech filing in April 2026: $3M. This offering is 36.2× the median.

Other California filings this week: 444 Capital - D'Amelio Family Fund I, LP, Angeles Private Markets Fund 6 LP, AQT Capital Fund, LP, C1 Group LLC, Camden Bonds Plus Fund, LLC

Leadership

Charles Baum — Executive Officer (also: Director)

James Christensen — Executive Officer (also: Director)

Grace Lu — Executive Officer

Reid Huber — Director

Daniel O'Connell — Director

Peter Thompson — Director

Michael Goller — Director

Filing details

Terremoto Biosciences, Inc. filed a Form D with the SEC on April 22, 2026.

Other newest Biotech companies

Other newest companies in California